Skip to main content

Want a detailed portfolio tracker?

AnaptysBio (ANAB) P/E (2017 - 2026)

AnaptysBio (ANAB) P/E from Jan 26, 2017 to Jul 21, 2026. The TTM AnaptysBio (ANAB) P/E is -60.82. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of AnaptysBio (ANAB)

YearP/EChange
2026-60.82-32.88%
2025-90.61+5139.05%
2024-1.73-33.76%
2023-2.61-39.36%
2022-4.31-60.99%
2021-11.04-43.66%
2020-19.59+549.50%
2019-3.02-82.78%
2018-17.51-50.24%
2017-35.19N/A

Comparison AnaptysBio (ANAB) P/E with competitors

AnaptysBio (ANAB) P/E is -60.82.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.00%
NBYStablecoin Development Corp0.00-100.01%
ENLVEnlivex Ltd0.07-100.12%
FGENFibroGen Inc0.24-100.39%
CHRSCoherus Biosciences Inc0.85-101.40%
FBIOFortress Biotech Inc0.95-101.56%
ORMPOramed Pharmaceuticals Inc1.50-102.47%
AGENAgenus Inc3.01-104.95%
INVAInnoviva Inc3.15-105.19%
VXRTVaxart Inc3.55-105.84%
CRMDCorMedix Inc3.63-105.97%
CVACCureVac N.V.4.45-107.31%
GLPGGalapagos NV4.86-107.99%
SRPTSarepta Therapeutics Inc4.88-108.03%
ABEOAbeona Therapeutics Inc5.39-108.86%
ABUSArbutus Biopharma Corp5.60-109.20%
ZVRAZevra Therapeutics Inc5.89-109.68%
SPROSpero Therapeutics Inc6.23-110.24%
CGENCompugen Ltd6.31-110.38%
RIGLRigel Pharmaceuticals6.87-111.30%
SLXNSilexion Therapeutics Corp7.30-112.00%
OMEROmeros Corporation9.26-115.22%
AUPHAurinia Pharmaceuticals Inc9.58-115.76%
PLXProtalix BioTherapeutics Inc10.89-117.91%
ACADAcadia Pharmaceuticals Inc11.73-119.28%
TBPHTheravance Biopharma Inc12.26-120.16%
ADMAAdma Biologics Inc12.42-120.42%
HRMYHarmony Biosciences Holdings Inc13.82-122.72%
SABSSAB Biotherapeutics Inc14.14-123.24%
NAGENiagen Bioscience Inc14.82-124.36%
INCYIncyte Corp15.82-126.02%
REGNRegeneron Pharmaceuticals Inc15.86-126.07%
PBYIPuma Biotechnology Inc17.32-128.47%
CPRXCatalyst Pharmaceuticals Inc17.44-128.67%
EXELExelixis Inc17.54-128.84%
TGTXTG Therapeutics Inc18.97-131.18%
MDXGMimedx Group Inc20.55-133.79%
XOMAXOMA Royalty Corp22.87-137.61%
ARGXArgen X SE24.30-139.95%
CTMXCytomX Therapeutics Inc24.82-140.81%
XOMAOXOMA Royalty Corp25.34-141.67%
HALOHalozyme Therapeutics Inc25.62-142.13%
XOMAPXOMA Royalty Corp25.67-142.21%
VRTXVertex Pharmaceuticals Inc27.99-146.03%
RPRXRoyalty Pharma plc - Class A28.69-147.17%
SLNOSoleno Therapeutics Inc29.02-147.71%
ASNDAscendis Pharma A/S30.09-149.47%
LGNDLigand Pharmaceuticals Inc - Class B37.91-162.34%
APLSApellis Pharmaceuticals Inc39.02-164.16%
BMRNBiomarin Pharmaceutical Inc42.21-169.41%
KRYSKrystal Biotech Inc45.34-174.56%
ONCBeiGene Ltd69.54-214.34%
PHARPharming Group N.V.75.03-223.36%
TECHBio-Techne Corp101.96-267.64%
VCELVericel Corp109.92-280.74%
ALNYAlnylam Pharmaceuticals Inc117.96-293.96%
GMABGenmab140.29-330.67%
TLXTelix Pharmaceuticals Ltd162.15-366.62%
CORTCorcept Therapeutics Inc212.86-449.99%